Revolutionary drug combination shows potential for treatment of fatal childhood cancer
Every year around 20 Australian children die from the incurable brain tumor, Diffuse Intrinsic Pontine Glioma (DIPG). The average age
Read more
Why Black Men Benefit From Immunotherapy for Prostate Cancer
New research conducted by scientists at Northwestern University finds Black men may have a genetic advantage when it comes to
Read more
Combo Disappoints in Metastatic Prostate Cancer
Combining the tyrosine kinase inhibitor saracatinib with docetaxel does not benefit patients with metastatic, castration-resistant prostate cancer (mCRPC), according to
Read more
Study reveals detailed map of glioblastoma in genetic, molecular detail
Glioblastoma is among the most aggressive and devastating of cancers. While rare compared with other cancers, it's the most common
Read more
Modified CRISPR/Cas9 complex targets specific histones
Finding a needle in a haystack is hard enough. But try finding a specific molecule on the needle. Rice University
Read more
Researchers develop platform to identify cancer mutations that may be responsive to drug therapies
A Cleveland Clinic-led team of researchers has developed a personalized genomic medicine platform that will help advance accelerate genomic medicine
Read more
GLS1 inhibitor selectively eliminates senescent cells, ameliorates age-associated disorders
Senescent cells accumulate in organs during aging, promote tissue dysfunction, and cause numerous aging-related diseases like cancer. The cells arise
Read more
AstraZeneca's Imfinzi drug fails in head and neck cancer trial
FILE PHOTO: The AstraZeneca logo is pictured outside the AstraZeneca office building in Brussels as part of the coronavirus disease
Read more
Cancer patients weren’t responding to therapy. Then they got a poop transplant.
For some cancer patients, a “poop transplant” could boost the positive effects of immunotherapy, a treatment designed to rally the
Read more
Fecal transplant turns cancer immunotherapy non-responders into responders
Researchers at UPMC Hillman Cancer Center and the National Cancer Institute (NCI) demonstrate that changing the gut microbiome can transform
Read more